Russell Investments Group Ltd. sold 44,632 shares of Encompass Health Co. (NYSE: EHC)

Russell Investments Group Ltd. reduced its holdings in Encompass Health Co. (NYSE: EHC – Get Rating ) by 11.5% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 343,631 shares of the company’s stock after selling 44,632 shares during the quarter. Russell Investments Group Ltd. owned about 0.34% of Encompass Health worth $15,539,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Sei Investments Co. raised its stake in shares of Encompass Health by 29.4% in the second quarter. Now Sei Investments Co. now owns 213,253 shares of the company’s stock valued at $12,010,000 after buying an additional 48,456 shares during the period. Mackenzie Financial Corp bought a new position in shares of Encompass Health in the second quarter valued at approximately $289,000. Mitsubishi UFJ Trust & Banking Corp boosted its stake in shares of Encompass Health by 12.4% in the second quarter. Mitsubishi UFJ Trust & Banking Corp now owns 8,996 shares of the company’s stock valued at $504,000 after buying an additional 995 shares during the period. Aptus Capital Advisors LLC purchased a new position in shares of Encompass Health during the third quarter valued at approximately $1,788,000. Finally, 1492 Capital Management LLC purchased a new position in shares of Encompass Health in the second quarter valued at approximately $221,000. 96.14% of the stock is currently owned by institutional investors.

Insiders place their bets

In related news, Director Greg D. Carmichael bought 1,830 shares of the stock in a transaction on Monday, October 31st. The stock was bought at an average price of $54.67 per share, for a total transaction of $100,046.10. Following the completion of the acquisition, the director now directly owns 10,546 shares in the company, valued at $576,549.82. The acquisition was disclosed in a legal filing with the Securities and Exchange Commission, which is available via this hyperlink. 2.70% of shares are owned by company insiders.

Encompass Health Trading down 0.7%

EHC opened at $61.39 on Friday. The stock has a market cap of $6.13 billion, a price-to-earnings ratio of 22.57, a P/E/G ratio of 2.61 and a beta of 1.03. The stock’s 50-day moving average is $59.01 and its 200-day moving average is $53.68. Encompass Health Co. has a one year low of $44.33 and a one year high of $74.61. The company has a debt-to-equity ratio of 1.59, a quick earnings ratio of 1.21, and a current ratio of 1.21.

Encompass Health (NYSE:EHC – Get Rating ) last posted its earnings results on Wednesday, October 26th. The company reported $0.67 earnings per share for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.01). The company had revenue of $1.09 billion for the quarter, compared to analysts’ expectations of $1.06 billion. Encompass Health had a return on equity of 15.59% and a net margin of 5.39%. On average, equities analysts predict that Encompass Health Co. will post 2.79 EPS for the current year.

The Wall Street analyst weighs in

A number of research firms recently commented on EHC. Stephens decreased their target price on Encompass Health from $60.00 to $58.00 and set an “overweight” rating for the company in a research note on Friday, October 28th. Raymond James lifted their price objective on Encompass Health from $65.00 to $72.00 and gave the company a “strong-buy” rating in a research note on Friday, October 28th. TheStreet upgraded Encompass Health from a “c+” rating to a “b-” rating in a research note on Wednesday, December 21st. Finally, initiated coverage on Encompass Health in a research note on Wednesday, October 12th. They assign a “hold” rating to the company. One investment analyst has rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. Encompass Health presently has a consensus rating of “Buy” and a consensus target price of $64.13, based on data from MarketBeat.

About Encompass Health

(Get Rating)

Encompass Health Corp. is committed to providing post-acute health care services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provide rehabilitation treatment and care for patients recovering from stroke and other neurological conditions, heart and lung disease, brain and spinal cord injuries, complex orthopedic conditions and amputations.

See also

Want to see what other hedge funds are holding EHC? Visit to get the latest 13F filings and insider trading for Encompass Health Co. (NYSE:EHC – Get Rating).

Institutional Ownership by Quarter for Encompass Health (NYSE:EHC)

This instant news alert is generated by narrative science technology and financial data from MarketBeat to provide readers with the fastest and most accurate reporting. This story was reviewed by the MarketBeat editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Before you consider Encompass Health, you’ll want to hear this.

MarketBeat tracks Wall Street’s top-rated and top-performing research analysts and the stocks they recommend to their clients daily. MarketBeat identified the five stocks that top analysts are quietly whispering to their clients to buy now, before the broader market takes a nosedive … and Encompass Health wasn’t on the list.

Although Encompass Health currently has a “Buy” rating among analysts, the top-rated analysts think these five stocks are better buys.

Check out the five stocks here

A Guide to Hedging High Short Interest Stocks

Leave a Comment

Your email address will not be published. Required fields are marked *